Diversity in medicinal chemistry space

Current Topics in Medicinal Chemistry

Volumn 6, Issue 1, 2006, Pages 3-18

  Gorse, Alain Dominique ^a  

^a Department of Bio Layer   (Australia)

Author keywords

Chemical space; Database; Descriptors; Diversity; Selection

Indexed keywords

CHEMICAL COMPOUND; DRUG; NATURAL PRODUCT; NEW DRUG; ORGANIC COMPOUND;

CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG ABSORPTION; DRUG DESIGN; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; GENETIC ALGORITHM; HIGH THROUGHPUT SCREENING; MEDICINAL CHEMISTRY; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; PHARMACOPHORE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN PROTEIN INTERACTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; ALGORITHM; CHEMICAL MODEL; METHODOLOGY; STRUCTURE ACTIVITY RELATION;

ALGORITHMS; CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; MODELS, CHEMICAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33644861784     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802606775193310     Document Type: Review

References (271)

1. Martin Y.C. Diverse viewpoints on computational aspects of molecular diversity. J. Comb. Chem. 2001, 3(3), 231-250.
2. Valler M.J.; Green D. Diversity screening versus focussed screening in drug discovery. Drug Discov. Today 2000, 5(7), 286-293.
3. Parker C.N.; Schreyer S.K. Application of chemoinformatics to high-throughput screening: practical considerations. Methods Mol. Biol. 2004, 275, 85-110.
4. Lajiness M.S.; Shanmugasundaram V. Strategies for the identification and generation of informative compound sets. Methods Mol. Biol. 2004, 275, 111-130.
5. Schuffenhauer A.; Popov M.; Schopfer U.; Acklin P.; Stanek J.; Jacoby E. Molecular diversity management strategies for building and enhancement of diverse and focused lead discovery compound screening collections. Comb. Chem. High Throughput Screen. 2004, 7(8), 771-781.
6. Harper G.; Pickett S.D.; Green D.V. Design of a compound screening collection for use in high throughput screening. Comb. Chem. High Throughput Screen. 2004, 7(1), 63-70.
7. Clark D.E.; Pickett S.D. Computational methods for the prediction of drug-likeness. Drug Discov. Today 2000, 5(2), 49-58.
8. Leeson P.D.; Davis A.M.; Steele J. Drug-like properties: guiding principles for design - or chemical prejudice? Drug Discov. Today: Technologies 2004, 1(3), 189-195.
9. Rishton G.M. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov. Today 2003, 8(2), 86-96.
10. Agrafiotis D.K. Multiobjective optimization of combinatorial libraries. J. Comput. Aided Mol. Des. 2002, 16(5 - 6), 335-356.
11. Gillet V. Reactant- and product-based approaches to the design of combinatorial libraries. J. Comput. Aided Mol. Des. 2002, 16(5 - 6), 371-380.
12. Gillet V.J. Designing combinatorial libraries optimized on multiple objectives. Methods Mol. Biol. 2004, 275, 335-354.
13. Schnur D.; Beno B.R.; Good A.; Tebben A. Approaches to target class combinatorial library design. Methods Mol. Biol. 2004, 275, 355-378.
14. Barker E.J.; Gardiner E.J.; Gillet V.J.; Kitts P.; Morris J. Further development of reduced graphs for identifying bioactive compounds. J. Chem. Inf. Comput. Sci. 2003, 43(2), 346-356.
15. Lengauer T.; Lemmen C.; Rarey M.; Zimmermann M. Novel technologies for virtual screening. Drug Discov. Today 2004, 9(1), 27-34.
16. Rarey M.; Stahl M. Similarity searching in large combinatorial chemistry spaces. J. Comput. Aided Mol. Des. 2001, 15(6), 497-520.
17. Gillet V.J.; Willett P.; Bradshaw J. Similarity searching using reduced graphs. J. Chem. Inf. Comput. Sci. 2003, 43(2), 338-345.
18. Sheridan R.P.; Kearsley S.K. Why do we need so many chemical similarity search methods? Drug Discov. Today 2002, 7(17), 903-911.
19. Golbraikh A.; Tropsha A. Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J. Comput. Aided Mol. Des. 2002, 16(5 - 6), 357-369.
20. Johnson M.A.; Maggiora G.M. Concepts and applications of molecular similarity.; Wiley: New York, 1990.
21. Patterson D.E.; Cramer R.D.; Ferguson A.M.; Clark R.D.; Weinberger L.E. Neighbourhood behaviour: a useful concept for validation of "molecular diversity" descriptors. J. Med. Chem. 1996, 39, 3049-3059.
22. Todeschini R, Consonni V. Handbook of molecular descriptors. Wiley-VCH ed. Weinheim: 2000.
23. Fechner U.; Schneider G. Evaluation of distance metrics for ligand-based similarity searching. Chembiochem. 2004, 5(4), 538-540.
24. Cheng A.; Diller D.J.; Dixon S.L.; Egan W.J.; Lauri G.; Merz K.M. Jr. Computation of the physio-chemical properties and data mining of large molecular collections. J. Comput. Chem. 2002, 23(1), 172-183.
25. Rhodes N.; Willett P.; Dunbar J.B. Jr.; Humblet C. Bit-string methods for selective compound acquisition. J. Chem. Inf. Comput. Sci. 2000, 40(2), 210-214.
26. Edgar S.J.; Holliday J.D.; Willett P. Effectiveness of retrieval in similarity searches of chemical databases: a review of performance measures. J. Mol. Graph. Model. 2000, 18(4-5), 343-357.
27. Cruciani G.; Pastor M.; Mannbold R. Suitability of molecular descriptors for database mining. A comparative analysis. J. Med. Chem. 2002, 45(13), 2685-2694.
28. Horvath D.; Jeandenans C. Neighborhood behavior of in silico structural spaces with respect to in vitro activity spaces-a novel understanding of the molecular similarity principle in the context of multiple receptor binding profiles. J. Chem. Inf. Comput. Sci. 2003, 43(2), 680-690.
29. Martin Y.C.; Kofron J.L.; Traphagen L.M. Do structurally similar molecules have similar biological activity? J. Med. Chem. 2002, 45(19), 4350-4358.
30. Ashton M.; Barnard J.; Casset F.; Charlton M.; Downs G.; Gorse D.; Holliday J.; Lahana R.; Willett P. Identification of diverse database subsets using property-based and fragment-based molecular descriptions. Quant. Struct. Act. Relat. 2002, 21(6), 598-604.
31. Pickett S. Multi-objective approaches to screening collection design and analysis of HTS data. The 229th ACS National Meeting [COMP104]. 2005.
32. Waldman M.; Li H.; Hassan M. Novel algorithms for the optimization of molecular diversity of combinatorial libraries. J. Mol. Graph. Model. 2000, 18(4-5), 412-426.
33. Pascual R.; Mateu M.; Gasteiger J.; Borrell J.I; Teixido J. Design and analysis of a combinatorial library of HEPT analogues: comparison of selection methodologies and inspection of the actually covered chemical space. J. Chem. Inf. Comput. Sci. 2003, 43(1), 199-207.
34. Jamois E.A.; Hassan M.; Waldman M. Evaluation of reagent-based and product-based strategies in the design of combinatorial library subsets. J. Chem. Inf. Comput. Sci. 2000, 40(1), 63-70.
35. Agrafiotis D.K.; Rassokhin D.N. A fractal approach for selecting an appropriate bin size for cell-based diversity estimation. J. Chem. Inf. Comput. Sci. 2002, 42(1), 117-122.
36. Lam R.L.H.; Welch W.J.; Young S.S. Uniform coverage designs for molecule selection. Technometrics 2002, 44, 99-109.
37. Young S.S.; Wang M.; Gu F. Design of diverse and focused combinatorial libraries using an alternating algorithm. J. Chem. Inf. Comput. Sci. 2003, 43(6), 1916-1921.
38. Turner D.B.; Tyrrell S.M.; Willett P. Rapid quantification of molecular diversity for selective database acquisition. J. Chem. Inf. Comput. Sci. 1997, 37, 18-22.
39. Agrafiotis D.K.; Labanov V.S. An efficient implementation of distance-based diversity measure based on k-d trees. J. Chem. Inf. Comput. Sci. 1998, 39(1), 51-58.
40. Hassan M.; Bielawski J.P.; Hempel J.C.; Waldman M. Optimization and visualization of molecular diversity of combinatorial libraries. Mol. Divers. 1996, 2(1-2), 64-74.
41. Mount J.; Ruppert J.; Welch W.; Jain A.N. IcePick: a flexible surface-based system for molecular diversity. J. Med. Chem. 1999, 42(1), 60-66.
42. Bayley M.J.; Willett P. Binning schemes for partition-based compound selection. J. Mol. Graph. Model. 1999, in press.
43. Pearlman R.S.; Smith K.M. Novel software tools for chemical diversity. Persp. Drug Discov. Des. 1998, 9, 339-353.
44. Brown R.D.; Hassan M.; Waldman M. Combinatorial library design for diversity, cost efficiency, and drug-like character. J. Mol. Graph. Model. 2000, 18(4-5), 427-37, 537.
45. Wright T.; Gillet V.J.; Green D.V.; Pickett S.D. Optimizing the size and configuration of combinatorial libraries. J. Chem. Inf. Comput. Sci. 2003, 43(2), 381-390.
46. Willett P.; Barnard J.M.; Downs G.M. Chemical similarity searching. J. Chem. Inf. Comput. Sci. 1998, 38(6), 983-996.
47. Maggiora G.M.; Shanmugasundaram V. Molecular similarity measures. Methods Mol. Biol. 2004, 275, 1-50.
48. Flower D.R. On the properties of bit string-based measures of chemical similarity. J. Chem. Inf. Comput. Sci. 1998, 38(3), 379-386.
49. Godden J.W.; Xue L.; Bajorath J. Combinatorial preferences affect molecular similarity/diversity calculations using binary fingerprints and Tanimoto coefficients. J. Chem. Inf. Comput. Sci. 2000, 40(1), 163-166.
50. Holliday J.D.; Salim N.; Whittle M.; Wilett P. Analysis and display of the size dependence of chemical similarity coefficients. J. Chem. Inf. Comput. Sci. 2003, 43(3), 819-828.
51. Livingstone D.J. The characterization of chemical structures using molecular properties. A survey. J. Chem. Inf. Comput. Sci. 2000, 40(2), 195-209.
52. Zyrianov Y. Distribution-based descriptors of the molecular shape. J. Chem. Inf. Model. 2005, 45(3), 657-672.
53. Gallegos A.; Girones X. Topological quantum similarity indices based on fitted densities: theoretical background and QSPR application. J. Chem. Inf. Model. 2005, 45(2), 321-326.
54. Willett P. Evaluation of molecular similarity and molecular diversity methods using biological activity data. Methods Mol. Biol. 2004, 275, 51-64.
55. Good A.C.; Hermsmeier M.A.; Hindle S.A. Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments. J. Comput. Aided Mol. Des. 2004, 18(7), 529-536.
56. Brown R.D. Descriptors for diversity analysis. Persp. Drug Discov. Des. 1997, 7/8, 31-49.
57. Xue L.; Bajorath J. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb. Chem. High Throughput Screen. 2000, 3(5), 363-372.
58. Bajorath J. Selected concepts and investigations in compound classification, molecular descriptor analysis, and virtual screening. J. Chem. Inf. Comput. Sci. 2001, 41(2), 233-245.
59. Gorse D.; Lahana R. Functional diversity of compound libraries. Curr. Opin. Chem. Biol. 2000, 4(3), 287-294.
60. Agrafiotis D.K.; Myslik J.C.; Salemme F.R. Advances in diversity profiling and combinatorial series design. Mol. Divers. 1999, Vol 4, Iss I, 1-22.
61. Gillet V.J. Background theory of molecular diversity. In Molecular Diversity in Drug Design; Kluwer Academic Publishers: London, 1999; pp 43-65.
62. Bender A.; Glen R.C. A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication. J. Chem. Inf. Comput. Sci. 2005, 45, Web Release Date: 05-Aug-2005.
63. Sun H. A universal molecular descriptor system for prediction of logP, logS, logBB, and absorption.(0095-2338).
64. Viswanadhan V.N.; Ghose A.K.; Revankar G.R.; Robins R.K. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 1989, 29(3), 163-172.
65. Bender A.; Mussa H.Y.; Glen R.C.; Reiling S. Molecular similarity searching using atom environments, information-based feature selection, and a naive Bayesian classifier. J. Chem. Inf. Comput. Sci. 2004, 44(1), 170-178.
66. Roche O.; Schneider P.; Zuegge J.; Guba W.; Kansy M.; Alanine A.; Bleicher K.; Danel F.; Gutknecht E.M.; Rogers-Evans M.; Neidhart W.; Stalder H.; Dillon M.; Sjogren E.; Fotouhi N.; Gillespie P.; Goodnow R.; Harris W.; Jones P.; Taniguchi M.; Tsujii S.; von der S.W.; Zimmermann G.; Schneider G. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. J. Med. Chem. 2002, 45(1), 137-142.
67. Sadowski J.; Kubinyi H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 1998, 41(18), 3325-3329.
68. Fechner U.; Paetz J.; Schneider G. Comparison of three holographic fingerprint descriptors and their binary counterparts. QSAR Comb. Sci. 2005, ASAP, NA.
69. Carhart R.E.; Smith D.H.; Venkataraghavan R. Atom pairs as molecular features in structure-activity studies: definition and applications. J Chem. Inf. Comput. Sci. 1985, 25, 64-73.
70. Chen X.; Reynolds C.H. Performance of similarity measures in 2D fragment-based similarity searching: comparison of structural descriptors and similarity coefficients. J. Chem. Inf. Comput. Sci. 2002, 42(6), 1407-1414.
71. Bender A.; Mussa H.Y.; Glen R.C.; Reiling S. Similarity searching of chemical databases using atom environment descriptors (MOLPRINT 2D): evaluation of performance. J. Chem. Inf. Comput. Sci. 2004, 44(5), 1708-1718.
72. Kearsley S.K.; Sallamack S.; Fluder E.; Andose J.D.; Mosley R.T.; Sheridan R.P. Chemical similarity using physiochemical property descriptors. J. Chem. Inf. Comput. Sci. 1996, 36, 118-127.
73. Cruciani G.; Pastor M.; Guba W. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur. J. Pharm. Sci. 2000, 11 Suppl 2, S29-S39.
74. Kier LB, Hall LH. Molecular structure description: The electropological state. London: Academic Press, 1999.
75. Klein C.T.; Kaiser D.; Ecker G. Topological distance based 3D descriptors for use in QSAR and diversity analysis. J. Chem. Inf. Comput. Sci. 2004, 44(1),200-209.
76. Teckentrup A.; Briem H.; Gasteiger J. Mining high-throughput screening data of combinatorial libraries: development of a filter to distinguish hits from nonhits. J. Chem. Inf. Comput. Sci. 2004, 44(2), 626-634.
77. Kearsley S.K.; Sallamack S.; Fluder E.M.; Andose J.D.; Mosley R.T.; Sheridan R.P. Chemical similarity using physiochemical property descriptors. J. Chem. Inf. Model. 1996, 36(1), 118-127.
78. Fechner U.; Franke L.; Renner S.; Schneider P.; Schneider G. Comparison of correlation vector methods for ligand-based similarity searching. J. Comput. Aided Mol. Des. 2003, 17(10), 687-698.
79. Lemmen C.; Lengauer T. Computational methods for the structural alignment of molecules. J. Comput. Aided Mol. Des. 2000, 14(3), 215-232.
80. Schuffenhauer A.; Gillet V.J.; Willett P. Similarity searching in files of three-dimensional chemical structures: analysis of the BIOSTER database using two-dimensional fingerprints and molecular field descriptors. J. Chem. Inf. Comput. Sci. 2000, 40(2), 295-307.
81. Doweyko A.M. 3D-QSAR illusions. J. Comput. Aided Mol. Des. 2004, 18(7), 587-596.
82. Good A.C.; Cho S.J.; Mason J.S. Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening. J. Comput. Aided Mol. Des. 2004, 18(7), 523 -527.
83. Mason J.S.; Morize I.; Menard P.R.; Cheney D.L.; Hulme C.; Labaudiniere R.F. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J Med. Chem. 1999, 42(17), 3251-3264.
84. Sheridan R.P.; Miller M.D.; Underwood D.J.; Kearsley S.K. Chemical similarity using geometric atom pair descriptors. J Chem. Inf. Model. 1996, 36(1), 128-136.
85. Brown R.D.; Martin Y.C. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding. J. Chem. Inf. Comput. Sci. 1997, 37, 1-9.
86. Matter H. Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. J. Med. Chem. 1997, 40(8), 1219-1229.
87. Matter H.; Potter T. Comparing 3D pharmacophore triplets and 2D fingerprints for selecting diverse compound subsets. J. Chem. Inf. Comput. Sci. 1999, 39, 1211-1225.
88. Horvath D.; Jeandenans C. Neighborhood behavior of in silico structural spaces with respect to in vitro activity spaces - a benchmark for neighborhood behavior assessment of different in silico similarity metrics. J. Chem. Inf. Comput. Sci. 2003, 43(2), 691-698.
89. chuffenhauer A.; Gillet V.J.; Willett P. Similarity searching in files of three-dimensional chemical structures: analysis of the BIOSTER database using two-dimensional fingerprints and molecular field descriptors. J. Chem. Inf. Comput. Sci. 2000, 40(2), 295-307.
90. MDL Information Systems Inc. homepage on URL: www.mdli.com.
91. Barnard Chemical Information Ltd. homepage on URL: http://www.bci.gb.com.
92. Tripos Inc. Unity chemical information software. [St Louis, MO]: homepage on URL:www.tripos.com.
93. Daylight Chemical Information Systems Inc. homepage on URL: www.daylight.com.
94. Xue L.; Godden J.W.; Bajorath J. Database searching for compounds with similar biological activity using short binary bit string representations of molecules. J. Chem. Inf. Comput Sci. 1999, 39(5), 881-886.
95. Xue L.; Godden J.W.; Bajorath J. Evaluation of descriptors and mini-fingerprints for the identification of molecules with similar activity. J. Chem. Inf. Comput. Sci. 2000, 40(5), 1227-1234.
96. Xue L.; Bajorath J. Accurate partitioning of compounds belonging to diverse activity classes. J. Chem. Inf. Comput Sci. 2002, 42(3), 757-764.
97. Xue L.; Godden J.W.; Bajorath J. Mini-fingerprints for virtual screening: design principles and generation of novel prototypes based on information theory. SAR QSAR. Environ. Res. 2003, 14(1),27-40.
98. Xue L.; Godden J.W.; Stahura F.L.; Bajorath J. Design and evaluation of a molecular fingerprint involving the transformation of property descriptor values into a binary classification scheme. J. Chem. Inf. Comput. Sci. 2003, 43(4), 1151-1157.
99. Raymond J.W.; Willett P. Effectiveness of graph-based and fingerprint-based similarity measures for virtual screening of 2D chemical structure databases. J. Comput. Aided Mol. Des. 2002, 16(1), 59-71.
100. Charton M.; Charton B.I. The nature of topological parameters. II The composition of topological parameters. J. Comput. Aided Mol. Des. 2003, 17(2 - 4), 211-221.
101. HQSAR Software Tripos Inc.
102. Waller C.L. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. J. Chem. Inf. Comput Sci. 2004, 44(2), 758-765.
103. Sutherland J.J.; O'Brien L.A.; Weaver D.F. A comparison of methods for modeling quantitative structure-activity relationships. J. Med. Chem. 2004, 47(22), 5541-5554.
104. Winkler D.A.; Burden F.R. Holographic QSAR of Benzodiazepines. Quant. Struct. Act. Relat, 1998, 17(03), 224-231.
105. Rodrigues C.R.; Flaherty T.M.; Springer C.; McKerrow J.H.; Cohen F.E. CoMFA and HQSAR of acylhydrazide cruzain inhibitors. Bioorg. Med Chem. Lett. 2002, 12(11), 1537-1541.
106. Good A.C.; Kuntz I.D. Investigating the extension of pairwise distance pharmacophore measures to triplet-based descriptors. J. Comput. Aided Mol. Des. 1995, 9(4), 373-379.
107. Pickett S.D.; Mason J.S.; McLay I.M. Diversity profiling and design using 3D pharmacophores: pharmacophore-derived queries (PDQ). J. Chem. Inf. Comput. Sci. 1996, 36, 1214-1223.
108. McGregor M.J.; Muskal S.M. Pharmacophore fingerprinting. 2. Application to primary library design. J. Chem. Inf. Comput. Sci. 2000, 40(1),117-125.
109. Garcia-Garcia A.; Galvez J.; Julian-Ortiz J.V.; Garcia-Domenech R.; Munoz C.; Guna R.; Borras R. Search of chemical scaffolds for novel antituberculosis agents. J. Biomol. Screen. 2005, 10(3), 206-214.
110. Marrero-Ponce Y.; Castillo-Garit J.A.; Olazabal E.; Serrano H.S.; Morales A.; Castanedo N.; lbarra-Velarde F.; Huesca-Guillen A.; Jorge E.; Valle A.d.; Torrens F.; Castro E.A. Tomocomd-Cardd, a novel approach for computer-aided rational drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds. J. Comput. Aided Mol. Des. 2004, 18(10), 615-634.
111. Lang S.A.; Kozyukov A.V.; Balakin K.V.; Skorenko A.V.; Ivashchenko A.A.; Savchuk N.P. Classification scheme for the design of serine protease targeted compound libraries. J. Comput. Aided Mol. Des. 2002, 16(11), 803-807.
112. Poroikov V.V.; Filimonov D.A. How to acquire new biological activities in old compounds by computer prediction. J. Comput. Aided Mol. Des. 2002, 16(11), 819-824.
113. Bruno-Blanch L.; Galvez J.; Garcia-Domenech R. Topological virtual screening: A way to find new anticonvulsant drugs from chemical diversity. Bioorg. Med. Chem. Lett. 2003, 13(16), 2749-2754.
114. Garcia-Garcia A.; Galvez J.; Julian-Ortiz J.V.; Garcia-Domenech R.; Munoz C.; Guna R.; Borras R. New agents active against Mycobacteriurn avium complex selected by molecular topology: a virtual screening method. J. Antimicrob. Chemother. 2004, 53(1),, 65-73.
115. Besalu E.; Ponec R.; Julian-Ortiz J.V. Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study. Mol. Divers. 2003, 6(2), 107-120.
116. Marrero P.Y.; Cabrera Perez M.A.; Romero Z., V; Gonzalez D.H.; Torrens F. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. J. Pharm. Pharm. Sci. 2004, 7(2), 186-199.
117. Bruno-Blanch L.; Galvez J.; Garcia-Domenech R. Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity. Bioorg. Med. Chem. Lett. 2003, 13(16), 2749-2754.
118. Gozalbes R.; Brun-Pascaud M.; Garcia-Domenech R.; Galvez J.; Girard P.M.; Doucet J.P.; Derouin F. Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening. Antimicrob. Agents Chemother. 2000, 44(10), 2764-2770.
119. Murcia-Soler M.; Perez-Gimenez F.; Nalda-Molina R.; Salabert-Salvador M.T.; Garcia-March F.J.; Cercos-del-Pozo R.A.; Garrigues T.M. QSAR analysis of hypoglycemic agents using the topological indices. J. Chem. Inf. Comput. Sci. 2001, 41(5), 1345-1354.
120. Basak S.C.; Balaban A.T.; Grunwald G.D.; Gute B.D. Topological indices: their nature and mutual relatedness. J. Chem. Inf. Comput Sci. 2000, 40(4), 891-898.
121. Randic M.; Zupan J. On interpretation of well-known topological indices. J. Chem. Inf. Comput. Sci. 2001, 41(3), 550-560.
122. Randic M.; Balaban A.T.; Basak S.C. On structural interpretation of several distance related topological indices. J. Chem. Inf. Comput. Sci. 2001, 41(3), 593-601.
123. Randic M. On characterization of molecular branching. J. Am. Chem. Soc. 1975, 97, 6609-6615.
124. Kier, L.B.; Hall, L.H. Molecular connectivity in structure-activity analysis. New York: John Wiley and Sons, 1986.
125. Kier L.B.; A shape index from molecular graphs. Quant Struct. Act. Relat. 1985, 4, 109-116.
126. Kier L.B. An index of molecular flexibility from Kappa shape attributes. Quant. Struct. Act. Relat. 1985, 8, 218-221.
127. Balaban A.T. Highly discriminating distance-based topological index. Chem. Phys. Lett. 1982, 89, 399-404.
128. Hall L.H.; Kier L.B. Determination of topological equivalence in molecular graphs from the topological state. Quant. Struct. Act. Relat 1990, 9, 115-131.
129. Charton M. The nature of topological parameters. I. Are topological parameters 'fundamental properties'? J. Comput Aided Mol. Des. 2003, 17(2 - 4), 197-209.
130. Moreau G.; Broto P. The autocorrelation of a topological structure: a new molecular descriptor. Nouv. J. Chim. 1980, 4, 359-360.
131. Moreau G.; Turpin C. Use of similarity analysis to reduce large molecular libraries to smaller sets of representative compounds. Analysis 1996, 24, 17-21.
132. Wagener M.; Sadowski J.; Gasteiger J. Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J. Am. Chem. Soc. 1995, 117, 7769-7775.
133. Schneider G.; Neidhart W.; Giller T.; Schmid G. "Scaffoldhopping: by topological pharmacophore search: A contribution to virtual screening. Angew. Chem. Int. Ed. Engl. 1999, 38(19), 2894-2896.
134. Labute P. A widely applicable set of descriptors. J. Mol. Graph. Model. 2000,18 (4-5), 464-477.
135. Labute P. Derivation and applications of molecular descriptors based on approximate surface area. Methods Mol. Biol. 2004, 275, 261-278.
136. Song M.; Breneman C.M.; Bi J.; Sukumar N.; Bennett K.P.; Cramer S.; Tugcu N. Prediction of protein retention times in anion-exchange chromatography systems using support vector regression. J. Chem. Inf. Comput. Sci. 2002, 42(6), 1347-1357.
137. Shahapurkar S.; Kawathekar N.; Chaturvedi S.C. Quantitative structure activity relationship studies of diaryl thiophen derivatives as selective COX-2 inhibitors. Pharmazie 2005, 60(4), 254-258.
138. Godden JW.; Xue L.; Bajorath J. Classification of biologically active compounds by median partitioning. J. Chem. Inf. Comput. Sci. 2002, 42(5), 1263-1269.
139. Godden J.W.; Bajorath J. Chemical descriptors with distinct levels of information content and varying sensitivity to differences between selected compound databases identified by SE-DSE analysis. J. Chem. Inf. Comput. Sci. 2002, 42(1), 87-93.
140. Pearlman R.S.; Smith K.M. Metric validation and the receptor-relevant subspace concept. J. Chem. Inf. Comput. Sci. 1999. 39, 28-35.
141. Benigni R.; Gallo G.; Giorgi F.; Giuliani A. On the equivalence between different descriptions of molecules: Value for computational approaches. J. Chem. Inf. Comput. Sci. 1999, Vol 39, Iss 3, 575-578.
142. Stanton D.T. Evaluation and use of BCUT descriptors in QSAR and QSPR studies. J. Chem. Inf. Comput. Sci. 1999, 39, 11-20.
143. Pirard B.; Pickett S.D. Classification of kinase inhibitors using BCUT descriptors. J. Chem. Inf. Comput. Sci. 2000, 40(6), 1431-1440.
144. Drakulic B.J.; Juranic Z.D.; Stanojkovic T.P.; Juranic I.O. 2-[(Carboxymethyl) sulfanyl]-4-oxo-4-arylbutanoic acids selectively suppressed proliferation of neoplastic human HeLa cells. A SAR/QSAR study. J. Med. Chem. 2005, 48(17), 5600-5603.
145. Gonzalez M.P.; Teran C.; Teijeira M.; Besada P.; Gonzalez-Moa M.J. BCUT descriptors to predicting affinity toward A3 adenosine receptors. Bioorg. Med. Chem. Lett. 2005, 15(15), 3491-3495.
146. Ford M.G.; Pitt W.R.; Whitley D.C. Selecting compounds for focused screening using linear discriminant analysis and artificial neural networks. J. Mol. Graph. Model. 2004, 22(6), 467-472.
147. Manallack D.T.; Pitt W.R.; Gancia E.; Montana J.G.; Livingstone D.J.; Ford M.G.; Whitley D.C. Selecting screening candidates for kinase and G protein-coupled receptor targets using neural networks. J. Chem. Inf. Comput. Sci. 2002, 42(5), 1256-1262.
148. Rarey M.; Dixon J.S. Feature trees: a new molecular similarity measure based on tree matching. J. Comput. Aided Mol. Des. 1998, 12, 471-490.
149. Harper G.; Bravi G.S.; Pickett S.D.; Hussain J.; Green D.V. The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data. J. Chem. Inf. Comput. Sci. 2004, 44(6), 2145-2156.
150. Brustle M.; Beck B.; Schindler T.; King W.; Mitchell T.; Clark T. Descriptors, physical properties, and drug-likeness. J. Med. Chem. 2002, 45(16), 3345-3355.
151. Lewis R.A.; Mason J.S.; McLay I.M. Similarity measures for rational set selection and analysis of combinatorial libraries: the Diverse Property-Derived approach. J. Chem. Inf. Comput. Sci. 1997, 37, 599-614.
152. Gillet V.J.; Willett P.; Bradshaw J. Identification of biological activity profiles using substructural analysis and genetic algorithms. J. Chem. Inf. Comput. Sci. 1998, 38(2), 165-179.
153. Menard P.R.; Mason J.S.; Morize I.; Bauerschmidt S. Chemistry space metrics in diversity analysis, library design, and compound selection. J. Chem. Inf. Comput. Sci. 1998, 38(6), 1204-1213.
154. Schnur D. Design and diversity analysis of large combinatorial libraries using cell-based methods. J. Chem. Inf. Comput. Sci. 1999, 39(1), 36-45.
155. Stanton D.T.; Morris T.W.; Roychoudhury S.; Parker C.N. Application of nearest-neighbor and cluster analyses in pharmaceutical lead discovery. J. Chem. Inf. Comput. Sci. 1999, 39, 21-27.
156. Beno B.R.; Mason J.S. The design of combinatorial libraries using properties and 3D pharmacophore fingerprints. Drug Discov. Today 2001, 6(5), 251-258.
157. Oprea T.I.; Zamora I.; Ungell A.L. Pharmacokinetically based mapping device for chemical space navigation. J. Comb. Chem. 2002, 4(4), 258-266.
158. Bemis G.W.; Murcko M.A. The properties of known drugs. 1. Molecular frameworks. J. Med Chem. 1996, 39(15), 2887-2893.
159. Bemis G.W.; Murcko M.A. Properties of known drugs. 2. Side chains. J. Med. Chem. 1999, 42(25), 5095-5099.
160. Xu J.; Stevenson J. Drug-like index: a new approach to measure drug-like compounds and their diversity. J. Chem. Inf. Comput. Sci. 2000, 40(5), 1177-1187.
161. Broughton H.B.; Watson I.A. Selection of heterocycles for drug design. J. Mol. Graph. Model. 2004, 23(1), 51-58.
162. Lipinski C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
163. Ghose A.K.; Viswanadhan V.N.; Wendoloski J.J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of know drug databases. J. Comb. Chem. 1999, 1, 55-68.
164. Oprea T.I. Property distribution of drug-related chemical databases. J. Comput. Aided Mol. Des. 2000, 14(3), 251-264.
165. Zheng S.; Luo X.; Chen G.; Zhu W.; Shen J.; Chen K.; Jiang H. A new rapid and effective chemistry space filter in recognizing a druglike database. J. Chem. Inf. Model. 2005, 45(4), 856-862.
166. Ajay; Walters P.W.; Murcko M.A. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules. J. Med. Chem. 1998, 41, 3314-3324.
167. Sadowki J.; Kubinyi H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 1998, 41, 3325-3329.
168. Frimurer T.M.; Bywater R.; Naerum L.; Lauritsen L.N.; Brunak S. Improving the odds in discriminating "drug-like" from "non drug-like" compounds. J. Chem. Inf. Comput. Sci. 2000, 40(6), 1315-1324.
169. Zemov V.V.; Balakin K.V.; Ivaschenko A.A.; Savchuk N.P.; Pletnev I.V. Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions. J. Chem. Inf. Comput. Sci. 2003, 43(6), 2048-2056.
170. Muller K.-R.; Ratsch G.; Sonnenburg S.; Mika S.; Grimm M.; Heinrich N. Classifying 'Drug-likeness' with kernel-based learning methods. J. Chem. Inf. Model. 2005, 45(2), 249-253.
171. Lajiness M.S.; Vieth M.; Erickson J. Molecular properties that influence oral drug-like behavior. Curr. Opin. Drug Discov. Devel. 2004, 7(4), 470-477.
172. Muegge I. Selection criteria for drug-like compounds. Med. Res. Rev. 2003, 23(3), 302-321.
173. Ajay. Predicting drug-likeness: why and how? Curr. Top. Med. Chem. 2002, 2(12), 1273-1286.
174. Egan W.J.; Walters W.P.; Murcko M.A. Guiding molecules towards drug-likeness. Curr. Opin. Drug Discov. Devel. 2002, 5(4), 540-549.
175. Maybridge. homepage on URL: http://www.maybridge.com.
176. Specs. homepage on URL: http://www.specs.net.
177. Gillet V.J.; Khatib W.; Willett P.; Fleming P.J.; Green D.V. Combinatorial library design using a multiobjective genetic algorithm. J. Chem. Inf. Comput. Sci. 2002, 42(2), 375-385.
178. Whitley D.C.; Ford M.G.; Livingstone D.J. Unsupervised forward selection: a method for eliminating redundant variables. J. Chem. Inf. Comput. Sci. 2000, 40(5), 1160-1168.
179. Gorse D.; Rees A.; Kaczorek M.; Lahana R. Molecular diversity and its analysis. Drug Discov. Today 1999, 4(6), 257-264.
180. Godden J.W.; Stahura F.L.; Bajorath J. Variability of molecular descriptors in compound databases revealed by Shannon entropy calculations. J. Chem. Inf. Comput. Sci. 2000, 40(3), 796-800.
181. Stahura F.L.; Godden J.W.; Bajorath J. Differential Shannon entropy analysis identifies molecular property descriptors that predict aqueous solubility of synthetic compounds with high accuracy in binary QSAR calculations. J. Chem. Inf. Comput. Sci. 2002, 42(3), 550-558.
182. Andersson P.M.; Linusson A.; Wold S.; Sjostrom M.; Lundstedt T.; Norden B. Design of small libraries for lead exploration. In Molecular Diversity in Drug Design; Kluwer Academic Publishers: London, 1999; pp 197-220.
183. Agrafiotis D.K.; Lobanov V.S. Nonlinear mapping networks. J. Chem. Inf. Comput. Sci. 2000, 40(6), 1356-1362.
184. Rassokhin D.N.; Lobanov V.S.; Agrafiotis D.K. Nonlinear mapping of massive data sets by fuzzy clustering and neural networks. J. Comput. Chem. 2001, 22, 373-386.
185. Agrafiotis D.K.; Rassokhin D.N.; Lobanov V.S. Multidimensional scaling and visualization of large molecular similarity tables. J. Comput. Chem. 2001, 22, 488-500.
186. Agrafiotis D.K.; Lobanov V.S. Multidimensional scaling of combinatorial libraries without explicit enumeration. J. Comput. Chem. 2001, 22, 1712-1722.
187. Kohonen T. Self-organization and associative memory. Berlin: Springer-Verlag, 1988.
188. Bayada D.M.; Hamersma H.; van Geerestein V.J. Molecular diversity and representativity in chemical databases. J. Chem. Inf. Comput. Sci. 1999, 39(1), 1-10.
189. Tominaga Y. Data structure comparison using box counting analysis. J. Chem. Inf. Comput. Sci. 1998, 38, 867-875.
190. Bernard P.; Golbraikh A.; Kireev D.; Chretien J.R.; Rozhkova N. Comparison of chemical databases: Analysis of molecular diversity with Self Organising Maps (SOM). Analysis 1998, 26, 233-341.
191. Lee M.L.; Schneider G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J. Comb. Chem. 2001, 3(3), 284-289.
192. Givehchi A.; Schneider G. Impact of descriptor vector scaling on the classification of drugs and nondrugs with artificial neural networks. J. Mol. Model. (Online) 2004, 10(3), 204-211.
193. Schneider P.; Schneider G. Collection of Bioactive Reference Compounds for Focused Library Design. QSAR Comb. Sci. 2003, 22(7), 713-718.
194. Mullin R. Drug Discovery: As high-throughput screening draws fire, researchers leverage science to put automation into perspective. Chem. Eng. News 2004, 82(30), 23-32.
195. Mosley R.T.; Culberson C.J.; Kraker B.; Feuston B.P.; Sheridan R.P.; Conway J.F.; Forbes J.K.; Chakravorty S.J.; Kearsley S.K. Bin reagent selector: using synthon analysis to visualize reagent properties and assist in combinatorial library design. J. Chem. Inf. Model. 2005, 45(1), 177-182.
196. Shemetulskis N.E.; Dunbar J.B. Jr.; Dunbar B.W.; Moreland D.W.; Humblet C. Enhancing the diversity of a corporate database using chemical database clustering and analysis. J. Comput. Aided Mol. Des. 1995, 9(5), 407-416.
197. Nilakantan R.; Nunn D.S. A fresh look at pharmaceutical screening library design. Drug Discov. Today 2003, 8(15), 668-672.
198. Downs G.M.; Barnard J.M. Clustering methods and their uses in computational chemistry. In Reviews in Computational Chemistry, Volume 18;Lipkowitz K.B.; Boyd D.B.; Eds; Wiley-VCH: New York, 2002; pp 1-40.
199. Barnard J.M.; Downs G.M. Clustering of chemical structures on the basis of 2-D similarity measures. J. Chem. Inf. Comput. Sci. 1992, 32, 644-649.
200. Jain A.K.; Murty M.N.; Flynn P.J. Data clustering: A review. ACM Comput. SurVeys 1999, 31(3), 264-323.
201. Downs G.M.; Willett P.; Fisanick W. Similarity searching and clustering of chemical-structure databases using molecular property data. J. Chem. Inf. Comput. Sci. 1994, 34(1), 1094-1102.
202. Brown R.D.; Martin Y.C. Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J. Chem. Inf. Comput. Sci. 1996, 36(3), 572-584.
203. Wild D.J.; Blankley C.J. Comparison of 2D fingerprint types and hierarchy level selection methods for structural grouping using Ward's clustering. J. Chem. Inf. Comput. Sci. 2000, 40(1), 155-162.
204. Willett P.; Winterman V.; Bawden D. Implementation of nearest-neighbor searching in an online chemical structure search system: Selection of compounds for biological testing and clustering of substructure search output. J. Chem. Inf. Comput. Sci. 1986, 26(1), 36-41.
205. Shemetulskis N.E.; Dunbar J.B.Jr.; Dunbar B.W.; Moreland D.W.; Humblet C. Enhancing the diversity of a corporate database using chemical database clustering and analysis. J. Comput. Aided Mol. Des. 1995, 9, 407-416.
206. Menard P.R.; Lewis R.A.; Mason J.S. Rational screening set design and compound selection: Cascaded clustering. J. Chem. Inf. Comput. Sci. 1998, 38, 497-505.
207. Doman T.N.; Cibulskis J.M.; McCray P.D.; Spangler D.P. Algorithm5: A technique for fuzzy similarity clustering of chemical inventories. J. Chem. Inf. Comput. Sci. 1996, 36, 1195-1204.
208. Stahl M.; Mauser H. Database clustering with a combination of fingerprint and maximum common substructure methods. J. Chem. Inf. Model. 2005, 45(3), 542-548.
209. Holliday J.D.; Rodgers S.L.; Willett P.; Chen M.Y.; Mahfouf M.; Lawson K.; Mullier G. Clustering files of chemical structures using the fuzzy k-means clustering method. J. Chem. Inf. Comput. Sci. 2004, 44(3), 894-902.
210. Bocker A.; Derksen S.; Schmidt E.; Teckentrup A.; Schneider G. A hierarchical clustering approach for large compound libraries. J. Chem. Inf. Model. 2005, ASAP.
211. Lajiness M.S. Dissimilarity-based compound selection techniques. Persp. Drug Discov. Des. 1998, 718, 65-84.
212. Clark R.D. OptiSim: An extended dissimilarity selection method for finding diverse representative subsets. J. Chem. Inf. Comput. Sci. 1997, 37, 1181-1188.
213. Snarey M.; Terrett N.K.; Willett P.; Wilton D.J. Comparison of algoritms for dissimilarity-based compound selection. J. Mol. Graph. Model. 1997, 15, 372-385.
214. Willett P. Dissimilarity-based algorithms for selecting structurally diverse sets of compounds. J. Comput. Biol. 1999, 6(3-4), 447-457.
215. Hudson B.D.; Hyde R.M.; Rahr E.; Wood J. Parameter based methods for compound selection from chemical databases. Quant. Struct. Act. Relat. 1996, 15, 285-289.
216. Nilakantan R.; Bauman N.; Haraki K.S. Database diversity assessment: new ideas, concepts, and tools. J. Comput. Aided Mol. Des. 1997, 11(5), 447-452.
217. Gobbi A.; Lee M.L. DISE: directed sphere exclusion. J. Chem. Inf. Comput. Sci. 2003, 43(1), 317-323.
218. Mason J.S.: Computational screening: large-scale drug discovery. Pharmainformatics: A trend guide 1999, 34-36.
219. Mason J.S.; Hermsmeier M.A. Diversity assessment. Curr. Opin. Chem. Biol. 1999, 3, 342-349.
220. Xue L.; Godden J.; Gao H.; Bajorath J. Identification of a preferred set of molecular descriptors for compound classification based on principal component analysis. J. Chem. Inf. Comput. Sci. 1999, 39, 699-704.
221. Xue L.; Stahura F.L.; Bajorath J. Cell-based partitioning. Methods Mol. Biol. 2004, 275, 279-290.
222. Godden J.W.; Bajorath J. Partitioning in binary-transformed chemical descriptor spaces. Methods Mol. Biol. 2004, 275, 291-300.
223. Godden J.W.; Xue L.; Kitchen D.B.; Stahura F.L.; Schermerhorn E.J.; Bajorath J. Median Partitioning: a novel method for the selection of representative subsets from large compound pools. J. Chem. Inf. Comput. Sci. 2002, 42(4), 885-893.
224. Agrafiotis D.K. Stochastic algorithms for maximizing molecular diversity. J. Chem. Inf. Comput. Sci. 1997, 37, 841-851.
225. Good A.C.; Lewis R.A. New methodology for profiling combinatorial libraries and screening sets: cleaning up the design process with HARPick. J. Med. Chem. 1997, 40(24), 3926-3936.
226. Brown R.D.; Martin Y.C. Designing combinatorial library mixtures using a genetic algorithm. J. Med. Chem. 1997, 40, 2304-2313.
227. Gobbi A.; Poppinger D. Genetic optimization of combinatorial libraries. Biotechnol. Bioeng. 1998, 61(1), 47-54.
228. Gillet V.J.; Willett P.; Bradshaw J.; Green D.V.S. Selecting combinatorial libraries to optimize diversity and physical properties. J. Chem. Inf. Comput. Sci. 1999, 39, 169-177.
229. Sheridan R.P.; SanFeliciano S.G.; Kearsley S.K. Designing targeted libraries with genetic algorithms. J. Mol. Graph. Model. 2000, 18(4-5), 320-34, 525.
230. Miller J.L.; Bradley E.K.; Teig S.L. Luddite: an information-theoretic library design tool. J. Chem. Inf. Comput. Sci. 2003, 43(1), 47-54.
231. Baurin N.; Baker R.; Richardson C.; Chen I.; Foloppe N.; Potter A.; Jordan A.; Roughley S.; Parratt M.; Greaney P.; Morley D.; Hubbard R.E. Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds. J. Chem. Inf. Comput. Sci. 2004, 44(2), 643-651.
232. ACD. homepage on URL: http://www.mdli.com.
233. ChemNavigator. homepage URL: http://www.chemnavigator.com.
234. Irwin J.J.; Shoichet B.K. ZINC - A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 2005, 45(1), 177-182.
235. NCI. homepage on URL: http://www.nci.nih.gov.
236. ChemBank. homepage on URL: http://chembank.med.harvard.edu.
237. Schreiber S.L. Stuart Schreiber: biology from a chemist's perspective. Drug Discov. Today 2004, 9(7), 299-303.
238. Burke Martin D.; Schreiber S.L. A planning strategy for diversity-oriented synthesis. Angew. Chem. Int. Ed. Engl, 2004, 43, 46-58.
239. NCBI. PubChem compound. homepage on URL: http://pubchem.ncbi.nlm..nih.gov.
240. NIH Roadmap. homepage on URL: http://nihroadmap.nih.gov/molecularlibraries/.
241. Cummins D.J.; Webster Andrews c.; Bentley J.A.; Cory M. Molecular diversity in chemical database: comparison of medicinal chemistry knowledge bases and database of commercially available compounds. J. Chem. Inf. Comput. Sci. 1996, 36, 750-763.
242. Nilakantan R.; Bauman N.; Haraki K.S. Database diversity assessment: new ideas, concepts, and tools. J. Comput. Aided Mol. Des. 1997, 11(5), 447-452.
243. McGregor M.J.; Pallai P.V. Clustering of large databases of compounds using the MDL "Keys" as structural descriptors. J. Chem. Inf. Comput. Sci. 1997, 37, 443-448.
244. Voigt J.H.; Bienfait B.; Wang S.; Nicklaus M.C. Comparison of the NCI open database with seven large chemical structural databases. J. Chem. Inf. Comput. Sci. 2001, 41(3), 702-712.
245. Bradley M. An overview of the diversity represented in commercially-available databases. J. Comput. Aided Mol. Des. 2002, 16(5-6), 301-309.
246. Cambridge Crystallographic Data Center. homepage on URL: http://www.ccdc.cam.ac.uk/.
247. Nikitin S.; Zaitseva N.; Demina, O.; Solovieva V.; Mazin E.; Mikhalev S.; Smolov M.; Rubinov A.; Vlasov P.; Lepikhin D.; Khachko D.; Fokin V.; Queen C.; Zosimov V. A very large diversity space of synthetically accessible compounds for use with drug design programs. J. Comput. Aided Mol. Des. 2005, 19(1), 47-63.
248. Schurer S.C.; Tyagi P.; Muskal S.M. Prospective exploration of synthetically feasible, medicinally relevant chemical space. J. Chem. Inf. Model. 2005, 45(2), 239-248.
249. Lewell X.Q.; Judd D.B.; Watson S.P.; Hann M.M. RECAP - retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci. 1998, 38(3), 511-522.
250. Schneider G.; Lee M.L.; Stahl M.; Schneider P. De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J. Comput. Aided Mol. Des. 2000, 14(5), 487-494.
251. Maureen Rouhi A. Rediscovering natural products. Chem. Eng. News 2003, 81(41), 77-78.
252. Newman D.J.; Cragg G.M.; Snader K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66(7), 1022-1037.
253. Strohl W.R. The role of natural products in a modern drug discovery program. Drug Discov. Today 2000, 5(2), 39-41.
254. Whittle M.; Willett P.; Klaffke W.; van Noort P. Evaluation of similarity measures for searching the dictionary of natural products database. J. Chem. Inf. Comput. Sci. 2003, 43(2), 449-457.
255. Feher M.; Schmidt J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 2003, 43(1), 218-227.
256. Bajorath J. Chemoinformatics methods for systematic comparison of molecules from natural and synthetic sources and design of hybrid libraries. J. Comput. Aided Mol. Des. 2002, 16(5-6), 431-439.
257. Weber L. High-diversity combinatorial libraries. Curr. Opin. Chem. Biol. 2000, 4(3), 295-302.
258. Kulkarni B.A.; Roth G.P.; Lobkovsky E.; Porco J.A., Jr. Combinatorial synthesis of natural product-like molecules using a first-generation spiroketal scaffold. J. Comb. Chem. 2002, 4(1), 56-72.
259. Shang S.; Tan D.S. Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries. Curr. Opin. Chem. Biol. 2005, 9(3), 248-258.
260. Messer R.; Fuhrer C.A.; Haner R. Natural product-like libraries based on non-aromatic, polycyclic motifs. Curr. Opin. Chem. Biol. 2005, 9(3), 259-265.
261. Webb T.R. Current directions in the evolution of compound libraries. Curr. Opin. Drug Discov. Devel. 2005, 8(3), 303-308.
262. Arya P.; Joseph R.; Gan Z.; Rakic B. Exploring new chemical space by stereocontrolled diversity-oriented synthesis. Chem. Biol. 2005, 12(2), 163-180.
263. Samiulla D.S.; Vaidyanathan V.V.; Arun P.C.; Balan G.; Blaze M.; Bondre S.; Chandrasekhar G.; Gadakh A.; Kumar R.; Kharvi G.; Kim H.O.; Kumar S.; Malikayil J.A.; Moger M.; Mone M.K.; Nagarjuna P.; Ogbu C.; Pendhalkar D.; Rao A.V.; Rao G.V.; Sarma V.K.; Shaik S.; Sharma G.V.; Singh S.; Sreedhar C.; Sonawane R.; Timmanna U.; Hardy L.W. Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery. Mol. Divers. 2005, 9(1-3), 131-139.
264. Schreiber S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 2000, 287, 1964-1969.
265. Schreiber S.L. The small-molecule approach to biology: Chemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology. Chem. Eng. News 2003, 81(March 3), 51-61.
266. Caner H.; Groner E.; Levy L.; Agranat I. Trends in the development of chiral drugs. Drug Discov. Today 2004, 9(3), 105-110.
267. Golbraikh A.; Tropsha A. QSAR modeling using chirality descriptors derived from molecular topology. J. Chem. Inf. Comput. Sci. 2003, 43(1), 144-154.
268. Villar H.O.; Koehler R.T. Comments on the design of chemical libraries for screening. Mol. Divers. 2000, 5(1), 13-24.
269. Ertl P. Cheminformatics analysis of organic substituents: identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups. J. Chem. Inf. Comput. Sci. 2003, 43(2), 374-380.
270. Bohacek R.S.; McMartin C.; Guida W.C. The art and practice of structure-based drug design: a molecular modeling perspective. Med. Res. Rev. 1996, 16(1), 3-50.
271. Walters P.W.; Stahl M.T.; Murcko M.A. Virtual screening - an overview. Drug Discov. Today 1998, 3(4), 160-178.